Intra-Cellular Therapies, Inc. reports

Company location: Bedminster, NJ
Fiscal year end: 31 December

Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 1,000 matching filings.

Per page

Current page

4

Filing date: 05 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 05 Feb 2024
Reporting date: 01 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144/A File 001-36274

144/A filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-87380

SC 13G/A filing

Filing date: 25 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 18 Jan 2024
Reporting date: 16 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 16 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 12 Jan 2024
Reporting date: 11 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 11 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Jan 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 03 Jan 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 02 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

Filing date: 15 Dec 2023
Reporting date: 13 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 13 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 01 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 14 Nov 2023
Reporting date: 13 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 13 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 08 Nov 2023
Reporting date: 06 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 06 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36274

144 filing

Filing date: 06 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing